首页> 美国卫生研究院文献>Cells >Urine-Derived Stem Cells: Applications in Regenerative and Predictive Medicine
【2h】

Urine-Derived Stem Cells: Applications in Regenerative and Predictive Medicine

机译:尿衍生干细胞:在再生医学和预测医学中的应用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Despite being a biological waste, human urine contains a small population of cells with self-renewal capacity and differentiation potential into several cell types. Being derived from the convoluted tubules of nephron, renal pelvis, ureters, bladder and urethra, urine-derived stem cells (UDSC) have a similar phenotype to mesenchymal stroma cells (MSC) and can be reprogrammed into iPSC (induced pluripotent stem cells). Having simple, safer, low-cost and noninvasive collection procedures, the interest in UDSC has been growing in the last decade. With great potential in regenerative medicine applications, UDSC can also be used as biological models for pharmacology and toxicology tests. This review describes UDSC biological characteristics and differentiation potential and their possible use, including the potential of UDSC-derived iPSC to be used in drug discovery and toxicology, as well as in regenerative medicine. Being a new cellular platform amenable to noninvasive collection for disease stratification and personalized therapy could be a future application for UDSC.
机译:尽管是一种生物废物,人类尿液中仍含有少量细胞,这些细胞具有自我更新的能力,并具有分化为几种细胞类型的潜力。源自肾脏,肾盂,输尿管,膀胱和尿道的曲折小管,尿液衍生干细胞(UDSC)的表型与间质基质细胞(MSC)相似,可以重新编程为iPSC(诱导性多能干细胞)。通过简单,安全,低成本和无创的收集程序,对UDSC的兴趣在过去十年中不断增长。 UDSC在再生医学应用中具有巨大潜力,还可以用作药理学和毒理学测试的生物学模型。这篇综述描述了UDSC的生物学特性和分化潜力及其可能的用途,包括UDSC衍生的iPSC在药物发现和毒理学以及再生医学中的潜力。作为适用于疾病分类和个性化治疗的无创收集的新细胞平台,可能会成为UDSC的未来应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号